Amyotrophic lateral sclerosis definition

Amyotrophic lateral sclerosis or “ALS” means a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord.
Amyotrophic lateral sclerosis or “ALS” means a progressive
Amyotrophic lateral sclerosis means muscular weakness and atrophy, evidence of anterior horn cell dysfunction, visible muscle fasciculation, spasticity, hyperactive deep tendon reflexes and extensor plantar reflexes, evidence of corticospinal tract involvement, dysarthria and dysphagia. The diagnosis must be made by a Specialist Medical Practitioner with appropriate neuromuscular testing such as electromyogram (EMG). The disease must result in significant physical impairment (as evidenced by the Insured’s permanent irreversible inability to perform independently at least three (3) of the Activities of Daily Living).

Examples of Amyotrophic lateral sclerosis in a sentence

  • Amyotrophic lateral sclerosis: increased 18F-FDG uptake in sub-cortical structures.

  • Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

  • Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998.

  • Amyotrophic lateral sclerosis: prolongation of life by non- invasive respiratory aids.

  • Amyotrophic lateral sclerosis and occupational exposure to electromagnetic fields.

  • Patrick Johnson, MD, MS; Pablo Avalos; Doniel Drazin, MD, MA; Harish Babu, MD, PhD; Chirag Gadkary Patil, MD, MS; Margaret Allred; Robert Lewis; Robert Baloh; Clive Svendsen Introduction: Amyotrophic lateral sclerosis (ALS) results in loss of motor neurons in the spinal cord and there is no known etiology, treatment, or cure.

  • ALS, Amyotrophic lateral sclerosis; AU, Australian; CA, Canadian; ESP, Exome Sequencing Project; IT, Italian; MAF, minor allele frequency; SP, Spanish; UK, United Kingdom; US, USA.CCNF accession NM_001761.

  • Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

  • Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid.

  • Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that primarily attacks motor neurons, leading to progressive and ultimately fatal denervation of skeletal muscle throughout the body.


More Definitions of Amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis means amyotrophic lateral sclerosis (ALS), as broadly defined, to include patients with mixed upper motor neuron (UMN) and lower motor neuron (LMN) pathology (classic ALS), primarily LMN disease (LMN-predominant ALS and progressive muscular atrophy) and primarily UMN disease (UMN-predominant ALS and primary lateral sclerosis).
Amyotrophic lateral sclerosis means unequivocal diagnosis by a consultant neurologist confirming well defined neurological deficit with persistent signs of involvement of the spinal nerve columns and the motor centers in the brain and with specific weakness and atrophy of the muscles of the extremities.

Related to Amyotrophic lateral sclerosis

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • Receptor means enclosed spaces, conduits, protected groundwater sources, drinking and non-drinking water wells, surface water bodies, and public water systems which when impacted by chemicals of concern may result in exposure to humans and aquatic life, explosive conditions or other adverse effects on health, safety and the environment as specified in these rules.

  • Opioid antagonist means a drug that binds to opioid

  • Vaccine means a specially prepared antigen which, upon administration to a person, will result in immunity and, specifically for the purposes of this rule, shall mean influenza and pneumococcal vaccines.

  • complex product means a product which is composed of multiple components which can be replaced permitting disassembly and re-assembly of the product.

  • Halogen means one of the chemical elements chlorine, bromine or iodine.

  • Biological diversity means the variability among living organisms from all sources including, inter alia, terrestrial, marine and other aquatic ecosystems and the ecological complexes of which they are part; this includes diversity within species, between species and of ecosystems.

  • Cannabinoid edible means food or potable liquid into which a cannabinoid concentrate, cannabinoid extract or dried marijuana leaves or flowers have been incorporated.

  • Cannabinoid means any of the chemical compounds that are the active constituents of marijuana.

  • Embryo/fetus means the developing human organism from conception until the time of birth.

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Cannabinoid extract means a substance obtained by separating cannabinoids from marijuana by:

  • Opioid means a drug that produces an agonist effect on opioid receptors and is indicated or used for the treatment of pain.

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Antibody means a molecule comprising or containing one or more immunoglobulin variable domains or any fragments, derivatives, variants or modifications thereof that bind to the same antigen.

  • COVID-19 symptoms means fever of 100.4 degrees Fahrenheit or higher, chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, or diarrhea, unless a licensed health care professional determines the person’s symptoms were caused by a known condition other than COVID-19.

  • genocide means any of the following acts committed with intent to destroy, in whole or in part, a national, ethnical, racial or religious group, as such:

  • Total tetrahydrocannabinol means the same as that term is defined in § 3.2-4112.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Corrosion inhibitor means a substance capable of reducing the corrosivity of water toward metal plumbing materials, especially lead and copper, by forming a protective film on the interior surface of those materials.

  • Tetrahydrocannabinol means the same as that term is defined in § 3.2-4112.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Gene Therapy means the introduction of a nucleic acid sequence encoding a protein intended for or otherwise conferring therapeutic benefit into a person for therapeutic purposes (i) by in vivo introduction for incorporation into cells of such person, or (ii) by ex vivo introduction into cells for transfer into a person.